Gillanders Sarah, Wild Matthew, Deighan Christopher, Gillanders David
NHS Lothian, Edinburgh, UK.
Am J Kidney Dis. 2008 Apr;51(4):651-62. doi: 10.1053/j.ajkd.2007.12.023.
Emotion regulation refers to the psychological strategies people use to cope with such stressors as hemodialysis therapy. These strategies are associated with a range of physical and psychological variation that may be related to kidney disease and its management. This study explores the associations of 2 emotion regulation strategies, reappraisal and suppression, and considers their impact on patient well-being and kidney disease management.
Cross-sectional study.
106 hemodialysis patients undergoing renal replacement therapy and 94 friends or relatives.
Reappraisal and suppression, measured by using the Emotion Regulation Questionnaire.
Outcome parameters were measures of affect, psychosocial functioning, and well-being, measured using the Positive and Negative Affect Scale, the Brief COPE questionnaire, the Kidney Disease Quality-of-Life Short Form, and the Brief Symptom Inventory.
The Emotion Regulation Questionnaire measured reappraisal and suppression. Greater use of reappraisal was associated with lower levels of anxiety (r = -0.22; P = 0.03) and greater acceptance of the disease (r = 0.20; P = 0.04). It was also associated with more experience (r = 0.26; P < 0.01) and expression (r = 0.23; P = 0.02) of positive emotion and less experience (r = -0.35; P < 0.01) and expression (r = -0.29; P < 0.01) of negative emotion. Suppression was associated with less positive emotional expression (r = -0.28; P < 0.01), greater levels of depression (r = 0.22; P = 0.03) and somatization (r = 0.25; P < 0.01), and greater dissatisfaction with the time spent dealing with their kidney disease (r = -0.21; P = 0.04). Suppression also was associated with less emotional coping (r = -0.29; P < 0.01) and greater dissatisfaction with the support received from other people (r = -0.34; P < 0.01).
The study focuses on emotion regulation strategies and well-being rather than clinical parameters; therefore, extensive medical data were not recorded.
Reappraisal has more positive clinical and psychosocial associations than suppression. The emotion regulation strategy used by hemodialysis patients has important implications for well-being and disease management.
情绪调节是指人们用来应对诸如血液透析治疗等压力源的心理策略。这些策略与一系列可能与肾脏疾病及其管理相关的生理和心理变化有关。本研究探讨了两种情绪调节策略——重新评价和抑制,并考虑它们对患者幸福感和肾脏疾病管理的影响。
横断面研究。
106名接受肾脏替代治疗的血液透析患者以及94名朋友或亲属。
使用情绪调节问卷测量重新评价和抑制。
结果参数包括情感、心理社会功能和幸福感的测量指标,使用积极和消极情感量表、简易应对方式问卷、肾脏病生活质量简表以及简明症状量表进行测量。
情绪调节问卷测量了重新评价和抑制。更多地使用重新评价与较低水平的焦虑相关(r = -0.22;P = 0.03)以及对疾病的更高接受度相关(r = 0.20;P = 0.04)。它还与更多的积极情绪体验(r = 0.26;P < 0.01)和表达(r = 0.23;P = 0.02)以及更少的消极情绪体验(r = -0.35;P < 0.01)和表达(r = -0.29;P < 0.01)相关。抑制与更少的积极情绪表达相关(r = -0.28;P < 0.01)、更高水平的抑郁(r = 0.22;P = 0.03)和躯体化(r = 0.25;P < 0.01),以及对处理肾脏疾病所花费时间的更大不满(r = -0.21;P = 0.04)。抑制还与更少的情绪应对相关(r = -0.29;P < 0.01)以及对从他人那里获得的支持的更大不满(r = -0.34;P < 0.01)。
本研究关注情绪调节策略和幸福感而非临床参数;因此,未记录大量医学数据。
与抑制相比,重新评价具有更积极的临床和心理社会关联。血液透析患者使用的情绪调节策略对幸福感和疾病管理具有重要意义。